RE: Porky's Festive Prediction26 Sep 2023 08:52
I don't have an agenda, i just post as i see it, free world, DYOR, taking into account your three points:-
1. Yes on paper that WAS the original business model, it didn't do clinical trials, its outsourced the lab work, took trial drugs at Uni level and got them positioned. Now the effort is all focused on a lab start up. They promised more than six new evaluations? Didn't deliver. Even if they added them now it would be at least another year from here, lost time, lost pipeline and increased cost base. Its no longer lean and mean. Its become a lifestyle lab business IMO.
2. You think finances are well managed do you? wasting cash they had from shareholders on bonus payments, a PR firm?? cash burn back up to where it was pre crash??. Sorry but Gerry was the FD at the first crash, still FD at the emergency placing and will still be FD at the next penny raise. IMO its not well managed, it was at first when Kevin started now its business as usual, so i totally disagree on that point.
3. Too right Directors should be buying shares, agree on that and Adam should be on the BOD and i agree on that also but they are too arrogant, they didn't want the guy on the BOD "he can add value on the science side" what utter crap he has ten times the experience of Suzy and the entire BOD put together. The guy has his own small bio business, he clearly had time to be a NED as he has joined APTA. Its a major blunder as i see it. I think Suzy likes it as it is, likes yes people around her and her salary has doubled over the last three years and been well rewarded. IMO they shafted the guy but he is too nice to see it. Business can be ruthless at times IMO.
Anyhow, our views differ @PM2022, you go back to ramping i will check in again at the placing, if they can pull it off. You should get some open reach news soon, the lab opening, some collab news maybe and some lab wins, some business should come in from Imogen they cant deliver absolute zero but ultimately its now down to Investor support as i see it simply due to the size of the cash burn but, that will be a hard one now due to the amount of times the existing investor base has been rinsed.
It would be the third placing at Turner Pope. Personally unless they make material cash burn reductions, change the board, the direction, this next placing is going to be a tough one to get underwritten but we will know soon enough. I will be mega impressed if Adam tips up yet more cash to pay directors at the next placing, why should he? there has to be an end to someone's generosity don't you think? i would be reducing my exposure for sure in his position not increasing it but that's his business.
Good luck to you